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Edited by Miguel De la RosaAbstract Arf proteins are guanine nucleotide binding proteins
that are implicated in endocytotic pathways and vesicle traﬃck-
ing. The two widely studied isoforms of Arf proteins (Arf1 and
Arf6) have diﬀerent cellular functions and localizations but sim-
ilar structures. Arf proteins have an N-terminal helix with a
covalently bound myristoyl group. Except structural models,
there are no three dimensional structures of the myristoylated
N-terminal peptide or the intact myristoylated Arf proteins.
However, understanding the role of both the myristoyl group
and the N-terminal helix based on the details of their molecular
structures is of great interest. In the solution structure of myri-
stoylated N-terminal peptide of Arf6 described here, the myri-
stoyl group folds toward the N-terminus to interact with the
hydrophobic residues in particular, the phenyl ring. Also, the
structure of the dodecylphosphocholine (DPC) micelle-bound of
the peptide together with paramagnetic studies showed that the
myristoyl group is inserted into the micelle while residues V4–
G10 interact with the surface of the micelle. The structural
diﬀerences between the unbound and micelle-bound myristoy-
lated N-terminal peptide of Arf6 involves the myristoyl group
and the side chains of the hydrophobic residues.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Myristoylated N-terminus of Arf6; Arf proteins;
NMR structure determination1. Introduction
Small GTP binding proteins of the ADP ribosylation factor
(Arf) family are extensively involved in membrane traﬃckingAbbreviations: Arf, adenosine diphosphate ribosylation factor; Arf6,
adenosine diphosphate ribosylation factor 6; Arf1, adenosine diphos-
phate ribosylation factor 1; GDP, guanosine-50-diphosphate; GTP,
guanosine-50-triphosphate; GTPcS, guanosine 50-O-(3-thiotriphos-
phate); DPC, dodecylphosphocholine; NMT, N-myristoyl transferase;
ArfGEFs, guanine nucleotide exchange factors for Arf proteins; Arf-
GAPs, GTPase-activating proteins for Arf proteins; Gd-DTPA, gad-
olinium diethylenetriaminepentaacetic acid; NMR, nuclear magnetic
resonance; NOE, nuclear Overhauser eﬀect; NOESY, nuclear Over-
hauser eﬀect spectroscopy; HSQC, heteronuclear single quantum
correlation; TOCSY, total correlation spectroscopy; HN(CO)CA, a
triple resonance NMR experiment that correlates the amide 1H and
15N with the preceding 13Ca; switch I, residues 32–45; switch II, resi-
dues 65–80; interswitch loop, residues 55–62
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doi:10.1016/j.febslet.2006.06.086events [1–3]. The most divergent members of the mammalian
Arf family, Arf1 and Arf6, have distinct cellular functions de-
spite sharing approximately 70% sequence identity. Adenosine
diphosphate ribosylation factor 1 (Arf1) regulates the recruit-
ment of vesicle coat polymers, including COPI, to the Golgi
apparatus [4–6]. In contrast, adenosine diphosphate ribosyla-
tion factor 6 (Arf6) is located at the plasma membrane and
inﬂuences the endosomal membrane traﬃc and actin organiza-
tion that regulate endocytosis and exocytosis [7–10]. Arf6 also
plays an important role in the invasiveness of cancer cells by
regulating invadopodia formation [11,12]. Arf proteins interact
with various regulatory and eﬀector proteins, including a grow-
ing number of guanine nucleotide exchange factors (ArfGEFs)
bearing a catalytic Sec7 domain and GTPase-activating
proteins (ArfGAPs) that catalyze GTP hydrolysis [13]. Arf
proteins undergo the guanosine-5 0-diphosphate–guanosine-5 0-
triphosphate (GDP–GTP) activation cycle that is common to
small GTP binding proteins, but they also feature a unique
membrane-driven switch [14,15].
Unlike other ras-like proteins, Arf proteins have a myristoy-
lated amphipathic N-terminal helix. Both the N-terminal helix
and the myristoyl group appear to contribute to the ability of
the protein to bind to membranes [16]. Binding to membranes
persists even without the myristoyl group [17], but removal of
the N-terminus not only aﬀects the binding of the protein to
membrane but also signiﬁcantly alters the activity of Arf pro-
teins [18]. Also, the GDP–GTP nucleotide exchange process
involves the rearrangement of the N-terminal helix and the
interswitch region [14,19]. Based on the biochemical and crys-
tallographic studies of Arf1, Arf1–GDP partitions between the
cytosol and a low aﬃnity complex with membranes, whereas
Arf1–GTP associates tightly with membranes. It is suggested
that the myristoylated N-terminal helix mediates this stable
interaction by unfolding upon binding GTP and inserting into
the lipid bilayer [14]. However, both Arf6–GDP and Arf6–
GTP are localized at the plasma membrane [20]. The structures
of both GDP- [21] and GTP-bound [19] unmyristoylated Arf1
and Arf6 are similar. The diﬀerence in the conformation of
Arf1 and Arf6 proteins are attributed to discrete sequence
changes between the two proteins and the shorter N-terminal
linker of Arf6 [21]. The N-terminus of Arf6–GDP, positioned
in the hydrophobic pocket opposite the nucleotide binding site,
is shorter than that of Arf1 by four residues but it does not
shorten the helix as expected from sequence alignments, in-
stead, it shortens the linker that connects the helix to the
protein core [21].
A wide variety of cellular proteins are myristoylated, partic-
ularly proteins involved in signal transduction pathways. Theblished by Elsevier B.V. All rights reserved.
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proteins catalyzed by N-myristoyl transferase (NMT), which
covalently attaches a myristoyl moiety to the glycine amide
bond. Protein myristoylation can play a role in structural
and thermodynamic stability of the protein [22,23]. N-myri-
stoylated proteins and peptides are of great interest and impor-
tance; however, to date only a few high resolution structures
have been determined and studied. The detailed solution struc-
tures of myristoylated recoverin [24,25], a calcium sensor pro-
tein, demonstrate that the binding of Ca2+ induces the
extrusion of the myristoyl group, enabling it to interact with
a membrane. Also, the structures of the anchor domain of
HIV-1 Nef protein [26] and the complex of myristoylated
CAP-23 peptide with calmodulin [27] have been determined.
Although myristoylation of Arf proteins has been shown to
be important in GDP–GTP nucleotide-binding kinetics [28],
recruitment of coat proteins [29] and activation of phospholi-
pase D (PLD) [18], so far the nuclear magnetic resonance
(NMR) structures of Arf1 [30,31] and crystal structures of
both Arf1 and Arf6 [4,14,19,21] have been determined in
unmyristoylated form or with the N-terminal helix removed.
We describe here the three-dimensional solution structure of
myristoylated N-terminal peptide of Arf6 (Myristoyl-
GKVLSKIFNGKE) in solution, the structure of the peptide
bound to micelles, and the binding surface of the peptide
bound to micelles by using a paramagnetic NMR relaxation
perturbation.2. Materials and methods
Both 15N labeled (only ﬁve amino acids [G2, V4, L5, F9 and G11] of
the peptide are labeled because of the high cost of making fully 15N la-
beled peptide) and unlabeled myristoylated N-terminal peptides of
Arf6 were synthesized by Anaspec, Inc. Deuterated dodecylphosph-
ocholine (DPC) was purchased from Avanti Lipids Inc. The peptides
were prepared for NMR by dissolving 1 mM of the peptide either in
100% D2O or 10% D2O solution in acetate buﬀer (pH 5.0). Five mM
peptide and 100 mM or 200 mM fully deuterated DPC micelles were
used to study the micelle-bound peptide. Paramagnetic studies were
carried out using gadolinium diethylenetriaminepentaacetic acid (Gd-Table 1
Structural statistics for the unbound and micelle-bound myristoylated Arf6
U
Total number of distance constraints 21
Distance constraint violation >0.5 A˚
Distance constraint violation >0.8 A˚
R.M.S. deviations from idealized geometry
Bonds (A˚)
Angles ()
Impropers ()
Ramachandran plotb
Most favored regions 5
Additionally allowed regions 4
Generously allowed regions
Disallowed regions
R.M.S. deviations from average structurec
Backbone heavy atoms (A˚)
All heavy atoms (A˚)
aThese statistics comprise the ensemble of the ﬁnal 12 structures with the lo
bRamachandran plot analysis of residues 2–10 was performed using Prochec
cCalculated for the helical residues 2–10.DTPA) [32]. An aqueous solution of Gd-DTPA (200 mM) was added
to the mixture of the myristoylated peptide and DPC micelles to give a
ﬁnal concentration of 2.7 mM Gd-DTPA. Some of the peaks were too
broad to analyze when the ﬁnal concentration of Gd-DTPA was fur-
ther increased.
All NMR experiments were carried out at 25 C on a 500 MHz Var-
ian Inova NMR spectrometer equipped with a cryogenic probe. Two-
dimensional, natural abundance 1H–13C and 1H–15N HSQC, 1H
TOCSY and nuclear Overhauser eﬀect spectroscopy (NOESY) spectra
were used to assign all carbon, nitrogen and hydrogen atoms of the
peptides, and NOESY spectra with mixing time of 100 ms were used
to obtain distance constraints. The chemical shift index analysis was
based on the chemical shifts of the alpha protons and alpha carbons
[33]. Structure calculations were performed using NIH-Xplor (Xplor-
NIH-2.9.9, NIH) [34], see Table 1. The myristoyl parameters were in-
cluded based on other aliphatic carbon and hydrogen atoms given in
NIH-Xplor parameters. NOE-derived distance restraints were classi-
ﬁed as 1.8–2.5, 1.8–3.5, 1.8–5.0 and 1.8–6.0 A˚ on the basis of the rela-
tive nuclear Overhauser eﬀect (NOE) cross-peak intensities. Most of
the 1H and 13C signals of the myristoyl group were assigned by a com-
bination of 1H, 13C HSQC and homonuclear TOCSY experiments to-
gether with careful inspection of the calculated structures obtained
with the use of distance restraints associated with unambiguously as-
signed myristoyl signals. HN(CO)CA was used to assign the C2 of
the myristoyl. The chemical shifts were consistent with the literature
values given for myristic acid [35]. A total of 50 structures were calcu-
lated with simulated annealing protocols starting with extended struc-
tures for each unbound and micelle-bound myristoylated N-terminal
peptide of Arf6. Of these, the ﬁnal 12 structures with the lowest energy
were selected and used in Figs. 1A and 2A. Proton signal intensities
measured in the presence and absence of 2.7 mM Gd-DTPA using
1 D 1H and 2D 1H TOCSY spectra were analyzed to study the binding
surface of the peptide to micelles.3. Results and discussion
3.1. Solution structure of myristoylated N-terminal peptide of
Arf6
Biochemical studies suggest that both the myristoyl group
and the N-terminal helix contribute to membrane binding,
activity of Arf proteins, and the rate of nucleotide exchange
[18,28,29]. Although the functions and localization of the
two widely studied Arf isoforms (Arf1 and Arf6) are diﬀerent,
their structures are similar [21]. Structural models were pro-
posed for bilayer-bound myristoylated N-terminal peptide ofN terminal peptidea
nbound Micelle bound
5 211
0 2
0 0
0.0016 ± 0.006 0.0032 ± 0.0018
1.7 ± 0.1 2.9 ± 0.2
1.9 ± 0.1 1.2 ± 0.3
2.4% 52.4%
7.6% 47.6%
0.0% 0.0%
0.0% 0.0%
0.21 ± 0.06 0.27 ± 0.16
0.50 ± 0.05 0.80 ± 0.18
west energy of the 50 structures calculated using Xplor-NIH [34].
k-NMR [40].
Fig. 1. NMR structure of the myristoylated N-terminal Arf6 peptide.
(A) Superposition of the 12 lowest energy structures. (B) The lowest
energy structure that shows the phenyl ring of F9 interaction with the
myristoyl. (C) Superposition of the N-terminal helix backbone (yellow)
of the crystal structure of the unmyristoylated Arf6–GDP [21] and the
NMR structure of myristoylated N-terminal Arf6 (blue). The myri-
stoyl moiety of the peptide is in green. Residue F9 of the peptide is in
purple and of the crystal structure is in red. The switch I, switch II and
the interswitch loop are in cyan. Only side chains of L33, L35 and F59
are shown to demonstrate the hydrophobic interactions with F9 of the
N-terminal. The GDP nucleotide is shown in space-ﬁlling model. The
remainder of the protein is in gray. The ﬁgures were drawn using
PyMOL (DeLano Scientiﬁc, LLC.).
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tures of the myristoylated N-terminus or the intact Arf pro-
teins. We determined the solution structure of the
myristoylated N-terminal peptide of Arf6 (Fig. 1A) using solu-
tion NMR. The information collected from the NOESY,
TOCSY and 1H–13C HSQC spectra were used for resonance
assignments, determining the secondary structure, and calcu-
lating the structure of the peptide. NOE peaks characteristic
of helical structure (NHi–
NHi+1,
aHi–
NHi+3) are observed for
residues V4–G10 (Table 2). Chemical shift index analysis
(CSI) [33] based on the deviation in the chemical shifts of alpha
protons and carbons from random coil showed a consensus of
helical secondary structure for residues K3–I8 (Table 2). Sev-
eral NOEs were observed between the myristoyl group and
the peptide; in particular, strong NOEs were observed between
the protons of the phenyl ring of residue F9 and the myristoyl
protons. Also, NOEs between the myristoyl protons and the
amide protons of G2, V4, L5 and I8 were observed. The struc-
ture of the myristoylated N-terminal peptide was calculated
based on 215 NOE 1H–1H distance and dihedral constraints.The NMR structure showed that the myristoyl group is folded
towards the peptide interacting with the hydrophobic residues,
particularly the phenyl ring (Fig. 1B). The myristoylated pep-
tide is quite soluble in the buﬀer solution that was used in our
experiments. One possible explanation for its high solubility is
that the myristoyl group is folded back to the peptide interact-
ing with the hydrophobic residues while the polar residues like
K3 and K7 pointing towards the solvent as it is evident from
the three dimensional structure of the myristoylated peptide.
To examine possible orientation of the myristoyl group with
respect to the intact protein, we aligned the backbone atoms of
the myristoylated N-terminal Arf6 peptide (G2–G10) with the
unmyristoylated N-terminal helix of the crystal structure of
Arf6–GDP [21] as shown in Fig. 1C, and the superimposition
indicates the similarity between the two helices. This may sug-
gest that the myristoyl group may not change the secondary
structure of the N-terminus of the Arf proteins although it
needs to be conﬁrmed with further studies on the intact myri-
stoylated Arf6. In the crystal structure of unmyristoylated
Arf6–GDP, F9 is buried in a hydrophobic pocket formed from
residues in Switch I, the interswitch loop, and the C-terminal
helix. In the unmyristoylated Arf6–GTPcS structure [19], the
N-terminal residues (G2–G10) are not visible, perhaps suggest-
ing a weak interaction with the remainder of the protein. The
isolated myristoylated peptide is a helix, with the myristoyl
group interacting with F9 and other hydrophobic side chains.
Based on the crystal structure of the unmyristoylated protein,
the N-terminal helix could be less likely to be associated with
the remainder of the protein in the GTP than in the GDP-
bound form. The GDP-bound Arf1 is cytosolic while the
myristoylated Arf6 protein has been shown to be membrane-
associated both in the GTP and GDP-bound forms. If the
interaction of the myristoyl group with the N-terminal helix
of the hydrophobic residues (particularly F9) occurs in the
intact myristoylated protein as it does in the myristoylated
N-terminus peptide, the myristoyl group would interfere with
the association of the N-terminal helix with the remainder of the
protein even in the GDP-bound form. This could promote the
interaction of Arf6 with the membrane in both the GTP- and
GDP-bound forms.3.2. The structure of the myristoylated N-terminal Arf6 with
DPC micelle
DPC has been used extensively to mimic the membrane envi-
ronment in the studies of the structure ofmembrane-bound pep-
tides and proteins [38]. The myristoylated peptide (5 mM) and
deuterated DPC (100 or 200 mM) were dissolved in acetate buf-
fer (pH 5) and NMR data required for chemical shift assign-
ments and distance constraints were collected. Most of the
chemical shifts of 1H, 15N and 13C of both backbone and side
chains were assigned based on natural abundance 1H–13C
HSQC and 1H–15N HSQC experiments in combination with
1H TOCSY and 1H NOESY experiments. 1H NOESY experi-
ment was used to obtain distance constraints for the structure
calculation. The presence of NOE peaks characteristic of helical
structure (NH–NHi+1,
aHi–
NHi+3) is observed for residues K3–
F9. Chemical shift index analysis also indicated helical second-
ary structure from residues K3–I8. The structure and chemical
shifts were identical for 100 and 200 mM DPC.
Signiﬁcant chemical shift changes were observed between
myristoylated peptide with and without DPC (Table 2). The
Fig. 2. NMR structure of the DPC micelle-bound myristoylated N-terminal Arf6. (A) Superposition of the 12 lowest energy structures. (B) The
lowest energy structure that shows the phenyl ring of F9 and the myristoyl pointing in the same direction (towards the micelle). (C) The ratio between
the proton signal intensities of the amide and the side chains of F9 and N11 for the DPC micelle-bound myristoylated N-terminal Arf6 in the
presence and absence of Gd-DTPA versus residues. (D) Space-ﬁlling model of the structure in (B) that shows the membrane binding surface of the
myristoylated N-terminal Arf6 as determined from the eﬀect of the paramagnetic relaxation of Gd-DTPA. Most aﬀected residues by the presence of
Gd-DTPA (G2, K3, K7, N11, K12 and E13) are in blue. Those residues (V4–S6) aﬀected moderately are in light yellow. Residues least aﬀected
(I8–G10) are in yellow. The myristoyl group is in green.
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the amide protons of G2 and K3, very likely a reﬂection of
the interaction of the myristoyl moiety with the DPC micelles.
The remainder of the chemical shift changes (0.1–0.2 ppm) was
found in the hydrophobic core of the peptide, in particular the
methyl groups of V4, L5, and I8 and the phenyl ring of F9.
This could reﬂect the change in chemical environment upon
binding DPC. Some of the myristoyl resonances were assigned,
and show changes in 1H and 13C chemical shifts. The chemical
shift diﬀerence between the two protons of C2, C3 and C4 of
the myristoyl in the micelle-bound forms are more dispersedas compared to the unbound myristoylated peptide, which
may suggest that the myristoyl group has more restricted mo-
tion because of its interaction with the micelle. Several NOEs
are observed between the myristoyl group and the peptide.
There are fewer contacts between the phenyl ring and the myr-
istoyl group for the bound than the unbound peptide, and
those that are present are much weaker for the micelle bound
peptide. The NOEs between the C2 of the myristoyl group and
amide proton of K3 are much stronger for the bound peptide.
This clearly indicates conformational changes between the un-
bound and micelle-bound myristoylated peptide. Structure of
Table 2
(A) Sequence alignment of the N-terminal of Arf1 and Arf6. The black
bar shows residues of the N-terminal helix based on the crystal
structures. (B) Summary of NMR data for unbound and micelle-
bound myristoylated N-terminal Arf6
Arf1 M G N I F A N L F K G L F G K K E 
Arf6 M G K V L S K I F G                               N K E 
Myr-Arf6     G K V L S K I F G N K E 
 N,N(i,i+2) 
, (i,i+3)
,N(i,i+3)
H -0.13 -0.21 -0.2 -0.25 -0.33 -0.21 -0.23 -0.07 0.09 -0.004 -0.016 -0.18
C 2.1    2.2    2.3   2.0    3.4   1.5    1.4     0.7   0.6   -0.3     -0.4    1.4
-helix (CSI)               *      *     *      *     *     *        
Myr-Arf6 (DPC micelle)  G K V L S K I F G N K E 
 N,N(i,i+2) 
, (i,i+3)
,N(i,i+3)
H -0.1   -0.17  -0.19  -0.1 -0.24 -0.15 -0.21 0.00 0.09 -0.01 -0.02 -0.11
C 3.0     2.2     2.7    2.5    3.3   2.3   1.4    0.6   0.7   -0.3   -0.3    0.5
-helix (CSI)          *   *    *   *     *    *      
Residue Numbers                   2     3    4    5     6    7    8     9    10   11   12   13 
HN      .6 .22 -.03 .02 .11 .0 -.02 .07 .1 .09 .03 .02 
*Change in chemical shift for alpha protons (
coil.  
1H ) and alpha carbons (13C ) from random
**Change in chemical shift of the amide protons between the micelle-bound and unbound 
A
B
forms of Myr-Arf6.  
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dihedral constraints (Fig. 2A and B). The myristoyl is not
folded towards the peptide instead the C2–C5 of the myristoyl
interacts mainly with the hydrophobic residues of the N-termi-
nal, and the remaining part of the myristoyl may be inserted in
the micelle. However, the myristoyl group was not well deﬁned
compared to the rest of the peptide because the micelle was not
included in the structure calculation due to the lack of readily
assignable NOEs between the micelle and the peptide.
3.3. Paramagnetic NMR relaxation perturbation to probe
membrane binding surface
Paramagnetic molecules can provide insight into the binding
surface of a peptide or protein bound to a micelle. Since the
eﬀect of nuclear paramagnetic relaxation is very sensitive to
the distances separating the target nuclei and paramagnetic
molecule, the increase in the relaxation rate of the target nuclei
can range from small to very large. For a micelle-bound pep-
tide or protein, line broadening and a decrease in signal inten-
sity is expected for protons exposed to the solution (i.e., close
to the paramagnetic molecule). Protons embedded in the mi-
celle are strongly protected and only a minor eﬀect is observed.
The binding surface of the myristoylated Arf6 peptide bound
to the micelle was examined by using a paramagnetic com-
pound, Gd-DTPA. In order to avoid losing signals completely
due to line broadening, the amount of Gd-DTPA was opti-
mized by varying its concentration. Gd-DTPA (2.7 mM) was
added to the myristoylated Arf6 peptide and DPC micelle solu-
tion, and the signal intensities of the protons of the peptide
using 1D 1H and 2D 1H TOCSY experiments were analyzedand compared to those determined in its absence. Fig. 2C
shows the ratio of the proton signal intensities with and with-
out Gd-DTPA for the amide protons and side chains of F9 and
N11 (the protons signals for the side chains of F9 and N11 are
well resolved). The intensity of the amine protons of the side
chain of N11 and the amide protons of G2, K3, K7, N11,
K12 and E13 were signiﬁcantly decreased, which indicates that
these residues, particularly the side chains of N11 are exposed
to the solvent. It is interesting to note that the chemical shift
changes for the unbound and micelle-bound amide protons
of G2 and K3 are signiﬁcant (Table 2) indicating that these res-
idues should be close to the micelles; therefore, one possible
explanation would be that the myristoyl anchors the peptide
and folds on residue V4 toward the surface of the micelle
exposing G2 and K3 residues to the aqueous solution. The
intensities for the backbone amide protons of V4–S6 were also
signiﬁcantly decreased indicating that these protons are likely
to be close to the micelles. However, the eﬀect of Gd-DTPA
is less visible for the amide protons of I8–G10, which implies
that they are more protected from Gd-DTPA and are facing
towards the micelles. The phenyl ring, in particular, HZ, is
the most protected, indicating that the phenyl ring is pointing
to the micelles (Fig. 2D).
Overall it seems that part of the myristoyl group is inserted
into the micelle and mainly the hydrophobic residues of the N-
terminal helix (V4–G10) interact with the micelle. Our NMR
data is consistent with previous point mutations studies which
showed that the mutations of F9A signiﬁcantly accelerated the
dissociation of Arf1–GTPcS from lipid vesicles [39].4. Conclusion
Myristoylation plays an important role in membrane bind-
ing, nucleotide exchange and the interaction of Arf with other
proteins. Previous crystal structures and NMR studies have fo-
cused on unmyristoylated Arf proteins because of the diﬃculty
of crystallizing and preparing the myristoylated protein. In the
absence of the structures of the intact myristoylated Arf pro-
teins, the solution and the micelle-bound structures of myri-
stoylated N-terminal peptide of Arf6 may provide insight
into the structural diﬀerences between the unbound and mi-
celle-bound myrisrtoylated N-terminus helix of Arf proteins.
In the unbound myristoylated N-terminal peptide, the myri-
stoyl group folds towards the N-terminal helix but when it
encounters the micelles, the myristoyl group partially dissoci-
ates from the peptide and inserts in the micelles, and this al-
lows both the myristoyl group and the hydrophobic face of
the N-terminal helix to stabilize the association of the peptide
with the micelles. If similar interactions occur between the
myristoyl group and the N-terminal helix in the intact protein,
myristoylation would modify the interaction of the hydropho-
bic face of the N-terminal helix with the hydrophobic patch or
perhaps even compete with those interactions, and this may
promote the interaction of the N-terminus with the membrane
in both the GDP- and GTP-bound forms. Because the crystal
structure of the GDP-bound unmyristoylated Arf6 shows that
the hydrophobic residues of the N-terminus, particularly the
phenyl ring, interact with the hydrophobic patch formed by
switch I and the interswitch loop regions of the protein, myris-
toylation could also be involved in the GDP–GTP nucleotide
exchange process. Future studies on the intact myristoylated
D. Gizachew, R. Oswald / FEBS Letters 580 (2006) 4296–4301 4301Arf proteins will provide more insight into the membrane-
switch mechanism of Arf proteins.
Data deposition. The coordinates of the ﬁnal 12 lowest en-
ergy structures of myristoylated N-terminal Arf6 of unbound
and micelle-bound peptides have been deposited in the Protein
Data Bank as entry 2BAO and 2BAU, respectively (http://
www.rcsb.org/pdb).
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